Survival Outcomes of Cervical Esophageal Cancer Treated with Definitive Chemoradiotherapy using Intensity modulated or 3D Conformal Radiation Therapy: A Single Institute Experience

Abstract
 Objective: The aim of this study is to report the survival and treatment results patients with cervical esophageal cancer treated definitive chemoradiotherapy, whose incidence very low in population there not enough information about toxicity literature. 
 Material Method: Between 2013 2022, 10 (six males four females) chemoradiotherapy were included. Among these patients, seven had stage II disease, one III, 2 IVA. All received radiotherapy at a median dose 50.4 Gy concurrent weekly chemotherapy.
 Results: follow-up period was 18 months. two-year 5-year overall rates 42.2% 21.1%, respectively. disease-free 45.7% 22.9%, Disease progression noted 3 out (30%). Three still alive during analyze. Percutaneous enteral gastrostomy performed patients. These requirement occured 1 due local progression, remaining side effect RT. Conclusions: Overall low, as similar findings appear It remarkable that need for percutaneous observed IMRT group. complete remission 2.